The US Drug Registry refers to the mandatory FDA system used to record drug manufacturing establishments and drug products that are legally marketed in the United States. Any company involved in manufacturing, processing, repacking, relabeling, or distributing drugs for the US market must comply with FDA drug registration and listing requirements enforced by the U.S. Food and Drug Administration (FDA).
Without proper FDA registration and drug listing, drug products cannot be legally imported, distributed, or sold in the United States.
What Is the US Drug Registry?
The US Drug Registry is part of the FDA’s regulatory framework under the Federal Food, Drug, and Cosmetic Act (FD&C Act). It allows the FDA to maintain visibility over:
- Drug manufacturing and processing facilities
- Drug products marketed in the US
- Companies responsible for regulatory compliance
The registry is maintained through two mandatory FDA requirements:
Both must be completed and kept up to date for legal market access.
Who Must Register in the US Drug Registry?
FDA drug registration applies to a wide range of pharmaceutical entities, including:
- Prescription drug manufacturers
- Over-the-counter (OTC) drug manufacturers
- Contract manufacturing organizations (CMOs)
- Repackers and relabelers
- Foreign drug manufacturers exporting to the US
Foreign companies must also appoint a US Agent, who serves as the FDA’s official point of contact for inspections and regulatory communication.
FDA Drug Establishment Registration
Drug establishment registration records the physical facility where drugs are manufactured or processed. Each facility must be registered separately, regardless of company ownership.
Key Points
- Registration is mandatory and renewed annually
- Renewal period: October 1 to December 31
- Applies to US and foreign establishments
- Required before importation or commercial distribution
Failure to renew establishment registration can result in inactive status, shipment delays, or import refusal.
FDA Drug Listing and NDC
After establishment registration, each drug product must be listed with the FDA. Drug listing includes details such as:
- Drug name and formulation
- Dosage form and strength
- Route of administration
- Manufacturer and labeler details
- National Drug Code (NDC)
The NDC is a unique identifier used across US supply chains, pharmacies, and reimbursement systems. While the FDA does not approve NDC numbers, accurate NDC configuration is essential for compliance.
Common US Drug Registry Compliance Issues
Companies often face regulatory challenges due to:
- Incorrect or incomplete SPL submissions
- Labeling inconsistencies
- Missed annual renewals
- Improper US Agent designation
- Confusion between FDA registration and approval
Even small administrative errors can delay product launches or disrupt shipments.
Why Professional FDA Registration Support Matters
Managing US Drug Registry compliance requires regulatory knowledge, technical accuracy, and ongoing monitoring. Mistakes can result in costly delays or enforcement actions.
XPRO America, a US FDA Consultancy, provides comprehensive FDA drug registration and listing services for pharmaceutical companies worldwide. Their support includes establishment registration, drug listing submissions, SPL preparation, NDC configuration, US Agent services, and annual renewal management.
For structured and compliant FDA registration support, organizations can connect with regulatory specialists at support@xproamerica.com.
Conclusion
The US Drug Registry is the foundation of legal drug distribution in the United States. Proper FDA establishment registration and drug listing are essential for compliance, import clearance, and long-term market access.
By maintaining accurate registration data and working with an experienced US FDA consultancy, companies can reduce compliance risk and operate confidently in the US pharmaceutical market.
Leave a Reply